The Chemours Company P/E Ratio 2013–2025
The Chemours Company reported 35.08 of price-to-earnings ratio for fiscal 2024. That was 373.3% higher than fiscal 2022. Compared with fiscal 2018, the change was +812.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | 35.08 | — |
| FY 2023 | — | — |
| FY 2022 | 7.41 | -7.3% |
| FY 2021 | 7.99 | -48.7% |
| FY 2020 | 15.59 | — |
| FY 2019 | — | — |
| FY 2018 | 3.84 | -58.7% |
| FY 2017 | 9.31 | -97.7% |
| FY 2016 | 400.35 | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
Source: The Chemours Company SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
The Chemours Company reported 35.08 of price-to-earnings ratio for fiscal 2024. That was 373.3% higher than fiscal 2022. Compared with fiscal 2018, the change was +812.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's price-to-earnings ratio?
The Chemours Company (CC) reported price-to-earnings ratio of 35.08 for fiscal year 2024, per its SEC filings.
How has The Chemours Company's price-to-earnings ratio changed over time?
Between fiscal 2013 and 2025, CC's price-to-earnings ratio declined at roughly 18.4% per year (compound annual rate), from 400.35 to 35.08.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More CC financial history
Full CC fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →